Featured Posts

To top
Title Image

Wall Tag

30 Nov

Ulta Beats Wall Street Forecasts, Increased Competition in Prestige

Ulta Beats Wall Street Forecasts, Increased Competition in Prestige
Ulta Beauty beat Wall Street’s top-line forecasts — though shoppers shied away from prestige in the corporate’s stores as competition heats up the category. Net sales increased 6.4 percent to $2.5 billion within the three months ended Oct. 28, in comparison with $2.3 billion a 12 months earlier, above analysts’ expectations for $2.47 billion. Skincare was once more its fastest-growing category, driven by double-digit growth within the mass and prestige segments. Among the many brands highlighted as growth drivers were Drunk Elephant, Good Molecules, La Roche Posey and Dermalogica. The fragrance and bath category delivered low-double-digit growth, while sales within the makeup category were flat, with midsingle-digit growth in mass makeup offsetting a modest decline in prestige makeup.  “While many mass brands proceed to...
Continue reading
16 Nov

Bath & Body Works Beats Wall Street Forecasts in

Bath & Body Works Beats Wall Street Forecasts in
Bath & Body Works beat Wall Street forecasts on the highest and bottom lines within the third quarter, however the crucial holiday season just isn't looking so strong. The retailer reported net sales of $1.56 billion for the third quarter ended Oct. 28, a decrease of two.6 percent in comparison with a 12 months ago, but above Wall Street estimates for $1.55 billion.  Net income was $119 million, up from $91 million in 2022. Adjusted earnings per diluted share was 48 cents, again beauty analysts’ forecasts for 35 cents.  Nevertheless, the corporate downgraded its full-year sales forecast. It now expects net sales to say no 2.5 percent to 4 percent. Previously it had forecast a drop of between 1.5 percent and three.5 percent. The...
Continue reading
18 Oct

P&G Beats Wall Street Forecasts in Q1 – WWD

P&G Beats Wall Street Forecasts in Q1 – WWD
Procter & Gamble beat Wall Street forecasts in the primary quarter on the back of upper pricing. The buyer goods giant, whose brands include Oral-B, Head & Shoulders, Olay, Gillette, SK-II and Pampers, saw first quarter fiscal yr 2024 net sales are available at $21.9 billion, up 6 percent versus a yr ago and barely above Wall Street forecast of $21.58 billion. Earnings per share were $1.83, also surpassing estimates of $1.72. “We delivered very strong leads to the primary quarter of fiscal yr 2024, putting us on the right track to deliver towards the upper end of our fiscal yr guidance ranges for organic sales and core EPS growth,” said Jon Moeller, chairman of the board, president and chief executive officer. “The...
Continue reading